Depuy Mitek

Monovisc

Manufacturer:

Depuy Mitek

Monovisc HCPCS:

J7327

HCPCS Code Descriptor:

Hyaluronan or derivative, monovisc, for intra-articular injection, per dose

Category:

J Code

Monovisc NDCs:

59676-0820-01

Primary Type:

Orthopedic

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

59676-0820-01

About Monovisc:

Monovisc is an Orthopedic drug manufactured by Depuy Mitek and administered via the Injection route of administration. The J Code: J7327 is aligned to the drug Monovisc.

Monovisc is an injection used for the treatment of osteoarthritis. Monovisc contains hyaluronic acid and is similar to the fluid that naturally surrounds the joints in your body. Monovisc is thought to work by mimicking this fluid and providing cushioning, lubricant, and shock absorption for the joint. Monovisc is given as an injection into the joint, typically the knee.

ACCESS PRICING AND MORE BY REGISTERING

J7327 Added Date:

January 1, 2015

J7327 Effective Date:

January 1, 2015

J7327 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Monovisc billing and coding information.
Monovisc patient assistance information can be found through the Johnson and Johnson Patient Assistance Foundation at the URL: http://www.jjpaf.org/
Monovisc prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for Monovisc. Please check back in a few weeks.